Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias - PubMed (original) (raw)
Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias
Jude Fitzgibbon et al. Cancer Res. 2005.
Abstract
Genome-wide single nucleotide polymorphism analysis has revealed large-scale cryptic regions of acquired homozygosity in the form of segmental uniparental disomy in approximately 20% of acute myeloid leukemias. We have investigated whether such regions, which are the consequence of mitotic recombination, contain homozygous mutations in genes known to be mutational targets in leukemia. In 7 of 13 cases with uniparental disomy, we identified concurrent homozygous mutations at four distinct loci (WT1, FLT3, CEBPA, and RUNX1). This implies that mutation precedes mitotic recombination which acts as a "second hit" responsible for removal of the remaining wild-type allele, as has recently been shown for the JAK2 gene in myeloproliferative disorders.
Similar articles
- Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias.
Raghavan M, Lillington DM, Skoulakis S, Debernardi S, Chaplin T, Foot NJ, Lister TA, Young BD. Raghavan M, et al. Cancer Res. 2005 Jan 15;65(2):375-8. Cancer Res. 2005. PMID: 15695375 - Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11.
Flotho C, Steinemann D, Mullighan CG, Neale G, Mayer K, Kratz CP, Schlegelberger B, Downing JR, Niemeyer CM. Flotho C, et al. Oncogene. 2007 Aug 23;26(39):5816-21. doi: 10.1038/sj.onc.1210361. Epub 2007 Mar 12. Oncogene. 2007. PMID: 17353900 - Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association.
Renneville A, Boissel N, Zurawski V, Llopis L, Biggio V, Nibourel O, Philippe N, Thomas X, Dombret H, Preudhomme C. Renneville A, et al. Cancer. 2009 Aug 15;115(16):3719-27. doi: 10.1002/cncr.24442. Cancer. 2009. PMID: 19536888 - Diagnostic implications of excessive homozygosity detected by SNP-based microarrays: consanguinity, uniparental disomy, and recessive single-gene mutations.
Kearney HM, Kearney JB, Conlin LK. Kearney HM, et al. Clin Lab Med. 2011 Dec;31(4):595-613, ix. doi: 10.1016/j.cll.2011.08.003. Epub 2011 Oct 20. Clin Lab Med. 2011. PMID: 22118739 Review. - C/EBPalpha mutations in acute myeloid leukaemias.
Nerlov C. Nerlov C. Nat Rev Cancer. 2004 May;4(5):394-400. doi: 10.1038/nrc1363. Nat Rev Cancer. 2004. PMID: 15122210 Review. No abstract available.
Cited by
- Whole Exome Sequencing of Intermediate-Risk Acute Myeloid Leukemia without Recurrent Genetic Abnormalities Offers Deeper Insights into New Diagnostic Classifications.
Guijarro F, Castaño-Díez S, Jiménez-Vicente C, Garrote M, Álamo JR, Gómez-Hernando M, López-Oreja I, Morata J, López-Guerra M, López C, Beà S, Costa D, Colomer D, Díaz-Beyá M, Rozman M, Esteve J. Guijarro F, et al. Int J Mol Sci. 2024 Aug 8;25(16):8669. doi: 10.3390/ijms25168669. Int J Mol Sci. 2024. PMID: 39201354 Free PMC article. - Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations.
Yuan J, He R, Alkhateeb HB. Yuan J, et al. Curr Hematol Malig Rep. 2023 Oct;18(5):121-129. doi: 10.1007/s11899-023-00699-3. Epub 2023 Jun 1. Curr Hematol Malig Rep. 2023. PMID: 37261703 Free PMC article. Review. - Cytogenetics analysis as the central point of genetic testing in acute myeloid leukemia (AML): a laboratory perspective for clinical applications.
Rosli AA, Azlan A, Rajasegaran Y, Mot YY, Heidenreich O, Yusoff NM, Moses EJ. Rosli AA, et al. Clin Exp Med. 2023 Aug;23(4):1137-1159. doi: 10.1007/s10238-022-00913-1. Epub 2022 Oct 13. Clin Exp Med. 2023. PMID: 36229751 Review. - Germline CEBPA mutation in familial acute myeloid leukemia.
Boada M, Catalán AI, Ottati C, Bentancour F, Lens D, Guillermo C, Grille S. Boada M, et al. Hematol Rep. 2021 Oct 4;13(3):9114. doi: 10.4081/hr.2021.9114. eCollection 2021 Sep 6. Hematol Rep. 2021. PMID: 34733449 Free PMC article. - Targeting Loss of Heterozygosity: A Novel Paradigm for Cancer Therapy.
Zhang X, Sjöblom T. Zhang X, et al. Pharmaceuticals (Basel). 2021 Jan 13;14(1):57. doi: 10.3390/ph14010057. Pharmaceuticals (Basel). 2021. PMID: 33450833 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous